Grant: Alliance Grants
Concordia University
$30,000.00
A digital microfluidic platform to automate the synthesis of aptamer-based biosensors_x000d_ _x000d_ _x000d_
FY 2020-21
Summary
In the FRQNT grant, the team of Shih and Wilds proposed to construct a new microfluidic platform that will drive down the costs of genome engineering which will be capable of accelerating the pace of genome synthesis. Our goal in the FRQNT grant is to use this platform to automate the genetic engineering process such that new cells can be quickly engineered for a variety of synthetic biology applications. Here in this proposal, we are expanding the application space and using our platform to synthesize COVID-19 aptamer-based biosensors. Due to their relatively simplistic configuration, aptamers are stable and highly sensitive for the detection of numerous applications (e.g., diseases and environmental monitoring). Typically aptamers are small, single-stranded oligonucelotides that are usually synthetically designed and manufactured. The main challenge is that the current technique to synthesize these aptamers result in very low yield, especially aptamers that are longer in length. Hence, we are joining forces with Dr. Maria DeRosa (Carleton University) to use our automated platform for the synthesis of aptamer-based biosensors. Given the pandemic, our goal is to use our automated platform to quickly synthesize aptamer-based biosensors for COVID-19. We believe with our system, we will be able to find aptamers that can rapidly detect COVID-19 with results in less than an hour at the location it was given. By improving on these efforts, we can make testing easier and more powerful with the hope of ending 'stay-at-home' orders.
_x000d_Dans le cadre de la subvention FRQNT, l'équipe de Shih et Wilds a proposé de construire une nouvelle plateforme microfluidique qui fera baisser les coûts de l'ingénierie du génome et qui sera capable d'accélérer le rythme de la synthèse du génome. L'obje
Program
Alliance Grants
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
560819-2020
Name nom
Shih, Steve
Department département
Electrical and Computer Engineering
Organization id
70
Institution établissement
Concordia University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
30000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
A digital microfluidic platform to automate the synthesis of aptamer-based biosensors_x000d_
_x000d_
_x000d_
Keyword
NSERC
Application summary
In the FRQNT grant, the team of Shih and Wilds proposed to construct a new microfluidic platform that will drive down the costs of genome engineering which will be capable of accelerating the pace of genome synthesis. Our goal in the FRQNT grant is to use this platform to automate the genetic engineering process such that new cells can be quickly engineered for a variety of synthetic biology applications. Here in this proposal, we are expanding the application space and using our platform to synthesize COVID-19 aptamer-based biosensors. Due to their relatively simplistic configuration, aptamers are stable and highly sensitive for the detection of numerous applications (e.g., diseases and environmental monitoring). Typically aptamers are small, single-stranded oligonucelotides that are usually synthetically designed and manufactured. The main challenge is that the current technique to synthesize these aptamers result in very low yield, especially aptamers that are longer in length. Hence, we are joining forces with Dr. Maria DeRosa (Carleton University) to use our automated platform for the synthesis of aptamer-based biosensors. Given the pandemic, our goal is to use our automated platform to quickly synthesize aptamer-based biosensors for COVID-19. We believe with our system, we will be able to find aptamers that can rapidly detect COVID-19 with results in less than an hour at the location it was given. By improving on these efforts, we can make testing easier and more powerful with the hope of ending 'stay-at-home' orders.
_x000d_Dans le cadre de la subvention FRQNT, l'équipe de Shih et Wilds a proposé de construire une nouvelle plateforme microfluidique qui fera baisser les coûts de l'ingénierie du génome et qui sera capable d'accélérer le rythme de la synthèse du génome. L'obje